BAM Management

Latest statistics and disclosures from BAM Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ONTY, BPAX, Genvec, RXII. These five stock positions account for 100.00% of BAM Management's total stock portfolio.
  • Added to shares of these 3 stocks: ONTY, BPAX, Genvec.
  • Reduced shares in these 1 stocks: RXII.
  • As of Sept. 30, 2011, BAM Management has $12.95M in assets under management (AUM). Assets under management grew from a total value of $10.70M to $12.95M.
  • Independent of market fluctuations, BAM Management was a net buyer by $5.21M worth of stocks in the most recent quarter.

BAM Management portfolio companies for September 2011 quarter

Company (Ticker) Portfolio Weight Share Count Price Last Trade
Oncothyreon (ONTY) 57.60 1.25M +66.00% 5.98 1.60
BioSante Pharmaceuticals (BPAX) 38.60 2.19M +89.00% 2.28 0.00
Genvec 2.42 109024 +20.00% 2.87 0.00
RXi Pharmaceuticals Corporation (RXII) 1.38 177406 -51.00% 1.01 1.16

Past 13F-HR SEC Filings for BAM Management

View All Filings